Citations 43
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience
Al‐Kali, Aref , Hussein, Ahmed Kamel Abou, Patnaik, Mrinal M. , Zblewski, Darci, Gangat, Naseema , Hashmi, Shahrukh K. , Elliott, Michelle A. , Hogan, William J. , Litzow, Mark R. , Abou Hussein, Ahmed Kamel, Patnaik, Mrinal , Hashmi, Shahrukh, Hogan, William J , Litzow, Mark R.
Leukemia & Lymphoma | February 21, 2018 | Volume: 59 | Issue: 11 | Pages: 2737-2739
ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis
Pardanani, Animesh , Finke, Christy M. , Zblewski, Darci, Abdelrahman, Ramy A., Wassie, Emnet A, Gangat, Naseema , Hanson, Curtis A. , Ketterling, Rhett P. , Tefferi, Ayalew , Pardanani, Animesh D, Lasho, Terra L. , Zblewski, Darci L, Ketterling, Rhett P
British Journal of Haematology | December 2, 2015 | Volume: 175 | Issue: 3 | Pages: 534-536
Concurrent activating KIT mutations in systemic mastocytosis
Finke, Christy M. , Zblewski, Darci, Hanson, Curtis A. , Ketterling, Rhett P. , Butterfield, Joseph H. , Tefferi, Ayalew , Pardanani, Animesh , Lasho, Terra L. , Ketterling, Rhett P
British Journal of Haematology | June 16, 2015 | Volume: 173 | Issue: 1 | Pages: 153-156